Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study

被引:180
作者
Vollmer, W. M. [1 ]
Gislason, P. [4 ]
Burney, P. [5 ]
Enright, P. L. [2 ]
Gulsvik, A. [6 ]
Kocabas, A. [7 ]
Buist, A. S. [3 ]
机构
[1] Kaiser Permanente, Ctr Hlth Res, Portland, OR 97227 USA
[2] Univ Arizona, Tucson, AZ USA
[3] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[4] Univ Iceland, Fac Med, Landspitali Univ Hosp, Reykjavik, Iceland
[5] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England
[6] Univ Bergen, Inst Med, Bergen, Norway
[7] Cukurova Univ, Sch Med, Adana, Turkey
基金
英国惠康基金;
关键词
Adult; chronic obstructive pulmonary disease; epidemiology; OBSTRUCTIVE PULMONARY-DISEASE; AIRWAY-OBSTRUCTION; REFERENCE VALUES; FEV1/FVC RATIO; LUNG-FUNCTION; PREVALENCE; ADULTS; RISK;
D O I
10.1183/09031936.00164608
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Published guidelines recommend spirometry to accurately diagnose chronic obstructive pulmonary disease (COPD). However, even spirometry-based COPD prevalence estimates can vary widely. We compared properties of several spirometry-based COPD definitions using data from the international Burden of Obstructive Lung Disease (BOLD)study. 14 sites recruited population-based samples of adults aged >= 40 yrs. Procedures included standardised questionnaires and post-bronchodilator spirometry. 10,001 individuals provided usable data. Use of the lower limit of normal (LLN) forced expiratory volume in 1 s (FEV1) to forced vital capacity (FVC) ratio reduced the age-related increases in COPD prevalence that are seen among healthy never-smokers when using the fixed ratio criterion (FEV1/FVC <0.7) recommended by the Global Initiative for Chronic Obstructive Lung Disease. The added requirement of an FEV1 either <80% predicted or below the LLN further reduced age-related increases and also led to the least site-to-site variability in prevalence estimates after adjusting for potential confounders. Use of the FEV1/FEV6 ratio in place of the FEV1/FVC yielded similar prevalence estimates. Use of the FEV1/FVC<LLN criterion instead of the FEV1/FVC <0.7 should minimise known age biases and better reflect clinically significant irreversible airflow limitation. Our study also supports the use of the FEV1/FEV6 as a practical substitute for the FEV1/FVC.
引用
收藏
页码:588 / 597
页数:10
相关论文
共 30 条
  • [1] International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study
    Buist, A. Sonia
    McBurnie, Mary Ann
    Vollmer, William M.
    Gillespie, Suzanne
    Burney, Peter
    Mannino, David M.
    Menezes, Ana M. B.
    Sullivan, Sean D.
    Lee, Todd A.
    Weiss, Kevin B.
    Jensen, Robert L.
    Marks, Guy B.
    Gulsvik, Amund
    Nizankowska-Mogilnicka, Ewa
    [J]. LANCET, 2007, 370 (9589) : 741 - 750
  • [2] Buist A Sonia, 2005, COPD, V2, P277, DOI 10.1081/COPD-200057610
  • [3] Population impact of different definitions of airway obstruction
    Celli, BR
    Halbert, RJ
    Isonaka, S
    Schau, B
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2003, 22 (02) : 268 - 273
  • [4] Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper
    Celli, BR
    MacNee, W
    Agusti, A
    Anzueto, A
    Berg, B
    Buist, AS
    Calverley, PMA
    Chavannes, N
    Dillard, T
    Fahy, B
    Fein, A
    Heffner, J
    Lareau, S
    Meek, P
    Martinez, F
    McNicholas, W
    Muris, J
    Austegard, E
    Pauwels, R
    Rennard, S
    Rossi, A
    Siafakas, N
    Tiep, B
    Vestbo, J
    Wouters, E
    ZuWallack, R
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2004, 23 (06) : 932 - 946
  • [5] Underestimation of airflow obstruction among young adults using FEV1/FVC &lt;70% as a fixed cut-off: a longitudinal evaluation of clinical and functional outcomes
    Cerveri, I.
    Corsico, A. G.
    Accordini, S.
    Niniano, R.
    Ansaldo, E.
    Anto, J. M.
    Kunzli, N.
    Janson, C.
    Sunyer, J.
    Jarvis, D.
    Svanes, C.
    Gislason, T.
    Heinrich, J.
    Schouten, J. P.
    Wjst, M.
    Burney, P.
    de Marco, R.
    [J]. THORAX, 2008, 63 (12) : 1040 - 1045
  • [6] The FEV1/FEV6 predicts lung function decline in adult smokers
    Enright, PL
    Connett, JE
    Bailey, WC
    [J]. RESPIRATORY MEDICINE, 2002, 96 (06) : 444 - 449
  • [7] Global burden of COPD: systematic review and meta-analysis
    Halbert, R. J.
    Natoli, J. L.
    Gano, A.
    Badamgarav, E.
    Buist, A. S.
    Mannino, D. M.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2006, 28 (03) : 523 - 532
  • [8] Spirometric reference values from a sample of the general US population
    Hankinson, JL
    Odencrantz, JR
    Fedan, KB
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (01) : 179 - 187
  • [9] Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers
    Hardie, JA
    Buist, AS
    Vollmer, WM
    Ellingsen, I
    Bakke, PS
    Morkve, O
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2002, 20 (05) : 1117 - 1122
  • [10] Hnizdo Eva, 2006, COPD, V3, P95, DOI 10.1080/15412550600651552